LimFlow provides health economics and reimbursement resources to support patient access to the TADV procedure with the LimFlow System. As LimFlow receives FDA approval, we will provide additional information and guidance.
Reimbursement Guide and Resources
The purpose of this information is to provide U.S. PROMISE III Category B IDE Clinical Study Sites with information to support reimbursement efforts related to the study.
Official Approval Letter from CMS
Available here on CMS’ List of Category B IDE Studies Approved for Coverage of the Category B device and related services, and routine services.
"*" indicates required fields